Adaptimmune Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 05/15/2025 | 27.40 M | $5.40 B | 0.00% | 1.78% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 05/15/2025 | 23.76 M | $4.68 M | 15.92% | 1.54% |
| TWO SEAS CAPITAL LP | 05/15/2025 | 20.53 M | $4.04 M | 38.39% | 1.33% |
| NEA MANAGEMENT COMPANY, LLC | 05/14/2025 | 17.08 M | $3.36 M | 0.00% | 1.11% |
| MPM ASSET MANAGEMENT LLC | 05/15/2025 | 5.34 M | $1.05 B | -3.96% | 0.35% |
| BIOIMPACT CAPITAL LLC | 05/15/2025 | 4.89 M | $964.19 K | -3.96% | 0.32% |
| MORGAN STANLEY | 05/15/2025 | 2.72 M | $535.04 K | 105.00% | 0.18% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 2.48 M | $489.24 M | 0.00% | 0.16% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 2.22 M | $424.00 K | 334.76% | 0.14% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 1.81 M | $357.33 K | -28.21% | 0.12% |
| FMR LLC | 05/12/2025 | 1.75 M | $345.71 K | -0.55% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.15 M | $225.96 K | -59.93% | 0.07% |
| JPMORGAN CHASE & CO | 05/12/2025 | 882.33 K | $173.82 K | -3.77% | 0.06% |
| RATHBONES GROUP PLC | 05/13/2025 | 432.82 K | $85.27 K | 0.00% | 0.03% |
| STATE STREET CORP | 05/15/2025 | 421.29 K | $83.00 K | 5.30% | 0.03% |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 05/15/2025 | 240.73 K | $47.42 K | 1,199.46% | 0.02% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 206.73 K | $40.73 K | 192.26% | 0.01% |
| BLACKROCK, INC. | 05/02/2025 | 183.69 K | $36.19 K | 0.00% | 0.01% |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 04/10/2025 | 150.15 K | $29.58 K | -41.20% | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 135.95 K | $26.78 K | 78.06% | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 109.07 K | $21.49 K | -21.98% | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 94.28 K | $18.57 K | 218.97% | 0.01% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 87.27 K | $17.19 K | 134.64% | 0.01% |
| CAPTRUST FINANCIAL ADVISORS | 05/15/2025 | 80.61 K | $15.88 K | -1.25% | 0.01% |
| INVESCO LTD. | 05/12/2025 | 78.03 K | $15.37 K | 23.20% | 0.01% |
| STATE OF TENNESSEE, TREASURY DEPARTMENT | 05/13/2025 | 73.38 K | $14.46 K | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 65.06 K | $13.01 K | 326.39% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 61.90 K | $12.19 K | 321.09% | 0.00% |
| SEI INVESTMENTS CO | 05/14/2025 | 54.82 K | $10.80 K | 100.00% | 0.00% |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 05/13/2025 | 54.72 K | $10.78 K | 100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 53.19 K | $10.49 K | 6,944.50% | 0.00% |
| NORTHERN TRUST CORP | 05/13/2025 | 51.33 K | $10.11 K | 0.00% | 0.00% |
| BARCLAYS PLC | 05/15/2025 | 50.07 K | $10.00 K | 0.01% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 40.70 K | $8.02 K | -36.37% | 0.00% |
| COLUMBIA ADVISORY PARTNERS LLC | 04/15/2025 | 36.53 K | $7.20 K | 122.47% | 0.00% |
| CSS LLC/IL | 05/15/2025 | 30.70 K | $6.05 K | 0.00% | 0.00% |
| SIMON QUICK ADVISORS, LLC | 04/15/2025 | 30.00 K | $5.91 K | 0.00% | 0.00% |
| NEWMAN DIGNAN & SHEERAR, INC. | 05/14/2025 | 27.96 K | $5.51 K | 0.00% | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 04/16/2025 | 26.82 K | $5.28 K | 0.00% | 0.00% |
| STIFEL FINANCIAL CORP | 05/14/2025 | 26.47 K | $5.22 K | 0.00% | 0.00% |
| HSBC HOLDINGS PLC | 05/14/2025 | 26.06 K | $5.22 K | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 25.26 K | $4.98 K | -18.73% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 21.97 K | $4.33 K | 12.47% | 0.00% |
| PROSPERITY WEALTH MANAGEMENT, INC. | 04/18/2025 | 19.80 K | $3.90 K | -9.47% | 0.00% |
| RHUMBLINE ADVISERS | 05/29/2025 | 18.31 K | $3.60 K | -7.27% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 17.34 K | $3.42 K | -40.50% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 16.15 K | $3.18 K | -0.07% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 15.60 K | $3.12 K | -20.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 14.20 K | $2.80 K | -12.88% | 0.00% |
| AUSDAL FINANCIAL PARTNERS, INC. | 05/15/2025 | 12.48 K | $2.46 K | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adaptimmune Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 99 institutional investors and hedge funds held shares of Adaptimmune Therapeutics plc. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 27.4 M
Long Focus Capital Management, LLC: 23.76 M
Two Seas Capital LP: 20.53 M
NEA Management Company, LLC: 17.08 M
MPM ASSET MANAGEMENT LLC: 5.34 M
BioImpact Capital LLC: 4.89 M
7.53% of Adaptimmune Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 115.63 M shares in the last 24 months. This purchase volume represents approximately $33.53 M in transactions.